Taurine inhibition of iron-stimulated catecholamine oxidation.
Dawson
R
R
Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville 32610, USA.
Tang
E
E
Shih
D
D
Hern
H
H
Hu
M
M
Baker
D
D
Eppler
B
B
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D002712:Chlorides; D005290:Ferric Compounds / Q000494:pharmacology; D007501:Iron / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007668:Kidney / Q000378:metabolism; D018374:LLC-PK1 Cells; D007980:Levodopa / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D010084:Oxidation-Reduction; D051381:Rats; D011916:Rats, Inbred F344; D013552:Swine; D013654:Taurine / Q000494:pharmacology*
D000975:Antioxidants; D002395:Catecholamines; D002712:Chlorides; D005290:Ferric Compounds; D013654:Taurine; D007980:Levodopa; D007501:Iron; C024555:ferric chloride